Emergency Epidemic Investigation Data Collections - Increase in Respondents

Forms and Documents

Document	Type	Status	Availability
Change Request.Increase Respondents. 11.5.2020 (003).docx	Justification for No Material/Nonsubstantive Change	Uploaded 2020-12-04	Available
Change Request 8.24.2020.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2020-09-01	Available
Appendix 2. Data Collection Forms.pdf	Supplementary Document	Uploaded 2020-04-15	Available
Appendix 1. Burden Memos.pdf	Supplementary Document	Uploaded 2020-04-07	Available
0920-1011 Non-Substantive Change Request Memo.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2020-04-07	Available
Appendix 1. Burden Memos.pdf	Supplementary Document	Uploaded 2020-02-12	Available
0920-1011 Non-Substantive Change Request Memo.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2020-02-12	Available
EEI_GenICR_SupSta A_FINAL.docx	Supporting Statement A	Uploaded 2020-01-15	Available
EEI GenICR_Sup St B.docx	Supporting Statement B	Uploaded 2020-01-15	Available
EEI GenICR 0920-13ZJ_App 6_Online Survey Case Finding Questionnaire_11-06-2013.docx	Supplementary Document	Uploaded 2013-11-20	Available
EEI GenICR 0920-13ZJ_App 5_Phone Interview Questionnaire Patient_11-06-2013_Subm.docx	Supplementary Document	Uploaded 2013-11-20	Available
EEI GenICR 0920-13ZJ_App 4_Q Fever Person Interview Questionnaire_11-14-2013_Subm.docx	Supplementary Document	Uploaded 2013-11-20	Available
EEI GenICR 0920-13ZJ_App 3 _Hantav Pulm Synd Questionnaire_11-14-2013_Subm.docx	Supplementary Document	Uploaded 2013-11-20	Available
EEI GenICR 0920-13ZJ_App 2_GBS Case Questionnaire_11-14-2013_Subm.docx	Supplementary Document	Uploaded 2013-11-20	Available
EEI GenICR 0920-13ZJ_App 1_Chart Abstract Form_11-14-2013_Subm.docx	Supplementary Document	Uploaded 2013-11-20	Repair queued
EEI GenICR 0920-13ZJ_Attach H_Biospecimen Storage Consent_11-06-2013_Subm.docx	Supplementary Document	Uploaded 2013-11-20	Available
Attach G _Emer Epi Invest_IRB Letter.pdf	Supplementary Document	Uploaded 2019-11-20	Available
EEI Gen ICR 0920-13ZJ_Attach F_Epi Invest SORN_11-06-2013.doc	Supplementary Document	Uploaded 2013-11-20	Available
Attach E _Burden Memo.docx	Supplementary Document	Uploaded 2016-10-13	Available
Attach D_Request for Approval.docx	Supplementary Document	Uploaded 2019-11-20	Available
Attach C_ Steps Conduct Emer Epi Invest.docx	Supplementary Document	Uploaded 2016-10-13	Available
60dy191011 Published_2019-19019.pdf	Supplementary Document	Uploaded 2020-01-15	Available
EEI GenICR_0920-13ZJ_Attach A_Auth Legis Emer Epi Invest_11-06-2013_Subm.pdf	Supplementary Document	Uploaded 2013-11-20	Available

IC Document Collections

IC ID	Collection	Type	Status	Form

ICR Details

OMB Control No: 0920-1011	ICR Reference No: 202012-0920-002
Status: Historical Active	Previous ICR Reference No: 202009-0920-002
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-1011-20RT/2
Title: Emergency Epidemic Investigation Data Collections - Increase in Respondents
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 12/10/2020
	Date Received in OIRA: 12/04/2020
Terms of Clearance: Previous terms continue: Approved consistent with the understanding that GenICs under this generic will be limited to acute public health emergencies resulting from outbreaks or events with undetermined agent, source, mode of transmission, or risk factors. Data collection for investigations conducted under this generic will not exceed 90 days. Investigations conducted for the primary purpose of program evaluation, surveillance, needs assessment, or research (e.g., to contribute to generalizable knowledge) are excluded from this generic pathway.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	01/31/2023	01/31/2023	01/31/2023
Responses	947,000	0	36,000
Time Burden (Hours)	473,500	0	473,500
Cost Burden (Dollars)	0	0	0

---

Abstract: The purpose of this non-substantive change request is for OMB approval for an increase in the number of respondents for this EEI generic ICR, which is necessary to ensure CDC’s ability to respond to the COVID-19 pandemic.

---

Authorizing Statute(s): US Code: 42 USC 301 Name of Law: PHSA
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	84 FR 46535	09/04/2019
30-day Notice:	Federal Register Citation:	Citation Date:
	84 FR 66908	12/06/2019
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 0

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	947,000	36,000	0	911,000	0	0
Annual Time Burden (Hours)	473,500	473,500	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $1,586,352

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Yes

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 12/04/2020

---